Literature DB >> 19630912

Impaired antibody responses but normal proliferation of specific CD4+ T cells in mice lacking complement receptors 1 and 2.

F Carlsson1, A Getahun, C Rutemark, B Heyman.   

Abstract

Severely impaired Ab responses are seen in animals lacking C (complement) factors C2, C3 or C4 as well as CR1/2 (C receptors 1 and 2). The molecular mechanism behind this phenomenon is not understood. One possibility is that C-containing immune complexes are endocytosed via CR2 on B cells and presented to specific CD4+ T cells, which would then proliferate and provide efficient help to specific B cells. In vitro, B cells can endocytose immune complexes via CR1/2 and present the Ag to T cells. Whether absence of this Ag presenting function in Cr2(-/-) mice (mice lacking CR1/2) explains their low Ab response is unclear. To address this question, Cr2(-/-) and wild type mice were transferred with OVA-specific T cells, obtained from the DO11.10 strain which has a transgenic TCR recognizing an OVA peptide. The animals were subsequently immunized with sheep red blood cells (SRBC) conjugated to OVA. Interestingly, proliferation of the OVA-specific T cells was normal in Cr2(-/-) mice, although their Ab response to both SRBC and OVA was severely impaired. These observations suggest that the impaired Ab response in Cr2(-/-) mice cannot be explained by a lack of appropriate induction of T cell help.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630912     DOI: 10.1111/j.1365-3083.2009.02274.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  11 in total

1.  Murine complement receptor 1 is required for germinal center B cell maintenance but not initiation.

Authors:  Luke R Donius; Janis J Weis; John H Weis
Journal:  Immunobiology       Date:  2014-02-25       Impact factor: 3.144

2.  Requirement for complement in antibody responses is not explained by the classic pathway activator IgM.

Authors:  Christian Rutemark; Elisabeth Alicot; Anna Bergman; Minghe Ma; Andrew Getahun; Stephan Ellmerich; Michael C Carroll; Birgitta Heyman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

3.  A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.

Authors:  Liudmila Kulik; Finnegan B Hewitt; Van C Willis; Rosa Rodriguez; Stephen Tomlinson; V Michael Holers
Journal:  Mol Immunol       Date:  2015-02       Impact factor: 4.407

4.  Targeting the Immune Complex-Bound Complement C3d Ligand as a Novel Therapy for Lupus.

Authors:  Liudmila Kulik; Jennifer Laskowski; Brandon Renner; Rachel Woolaver; Lian Zhang; Taras Lyubchenko; Zhiying You; Joshua M Thurman; V Michael Holers
Journal:  J Immunol       Date:  2019-11-15       Impact factor: 5.422

5.  Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1.

Authors:  Luke R Donius; Jennifer M Handy; Janis J Weis; John H Weis
Journal:  J Immunol       Date:  2013-06-03       Impact factor: 5.422

6.  IgE-mediated enhancement of CD4+ T cell responses in mice requires antigen presentation by CD11c+ cells and not by B cells.

Authors:  Frida Henningsson; Zhoujie Ding; Joakim S Dahlin; Marius Linkevicius; Fredrik Carlsson; Kjell-Olov Grönvik; Jenny Hallgren; Birgitta Heyman
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

7.  Complement-activating IgM enhances the humoral but not the T cell immune response in mice.

Authors:  Zhoujie Ding; Anna Bergman; Christian Rutemark; Rika Ouchida; Hiroshi Ohno; Ji-Yang Wang; Birgitta Heyman
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

8.  Complement receptors 1 and 2 in murine antibody responses to IgM-complexed and uncomplexed sheep erythrocytes.

Authors:  Christian Rutemark; Anna Bergman; Andrew Getahun; Jenny Hallgren; Frida Henningsson; Birgitta Heyman
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

9.  EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells.

Authors:  Jianhua Li; Erick Lu; Tangsheng Yi; Jason G Cyster
Journal:  Nature       Date:  2016-05-05       Impact factor: 49.962

10.  IgG Suppresses Antibody Responses in Mice Lacking C1q, C3, Complement Receptors 1 and 2, or IgG Fc-Receptors.

Authors:  Joakim J E Bergström; Birgitta Heyman
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.